A phase III study of adjuvant docetaxel, capecitabine and oxaliplatin triplet vs capecitabine and oxaliplatin doublet in patients with curatively resected stage IIIB or IV(M0) (AJCC 6th ed) gastric adenocarcinoma (TRIUMPH, KCSG ST14-05)

  • Ryu, M-H.
  • Zang, D. Y.
  • Lee, K-W.
  • Shim, B. Y.
  • Lee, M. H.
  • 외 2명
Citations

WEB OF SCIENCE

0
제목
A phase III study of adjuvant docetaxel, capecitabine and oxaliplatin triplet vs capecitabine and oxaliplatin doublet in patients with curatively resected stage IIIB or IV(M0) (AJCC 6th ed) gastric adenocarcinoma (TRIUMPH, KCSG ST14-05)
저자
Ryu, M-H.Zang, D. Y.Lee, K-W.Shim, B. Y.Lee, M. H.Rha, S. Y.Kang, Y-K.
발행일
2018-10
유형
Meeting Abstract
저널명
Annals of Oncology
29